5-138873611-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000274711.7(LRRTM2):c.950C>T(p.Ala317Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,613,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000274711.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRTM2 | NM_015564.3 | c.950C>T | p.Ala317Val | missense_variant | 2/2 | ENST00000274711.7 | NP_056379.1 | |
CTNNA1 | NM_001903.5 | c.1063-12601G>A | intron_variant | ENST00000302763.12 | NP_001894.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRTM2 | ENST00000274711.7 | c.950C>T | p.Ala317Val | missense_variant | 2/2 | 1 | NM_015564.3 | ENSP00000274711.5 | ||
CTNNA1 | ENST00000302763.12 | c.1063-12601G>A | intron_variant | 1 | NM_001903.5 | ENSP00000304669.7 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000210 AC: 52AN: 247724Hom.: 0 AF XY: 0.000186 AC XY: 25AN XY: 134416
GnomAD4 exome AF: 0.000138 AC: 202AN: 1461680Hom.: 0 Cov.: 33 AF XY: 0.000140 AC XY: 102AN XY: 727122
GnomAD4 genome AF: 0.000197 AC: 30AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2022 | The c.950C>T (p.A317V) alteration is located in exon 2 (coding exon 2) of the LRRTM2 gene. This alteration results from a C to T substitution at nucleotide position 950, causing the alanine (A) at amino acid position 317 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at